Related references
Note: Only part of the references are listed.30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective
Amit Sharma et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation
Xiaolong Wu et al.
FRONTIERS IN IMMUNOLOGY (2021)
DNA Methylation and Bladder Cancer: Where Genotype does not Predict Phenotype
Amit Sharma et al.
CURRENT GENOMICS (2020)
Increase of Antitumoral Effects of Cytokine-Induced Killer Cells by Antibody-Mediated Inhibition of MICA Shedding
Xiaolong Wu et al.
CANCERS (2020)
Ten-year update of the international registry on cytokine-induced killer cells in cancer immunotherapy
Ying Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma
Ying Zhang et al.
CANCERS (2020)
Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma
Su Jong Yu et al.
JOURNAL OF HEPATOLOGY (2019)
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Xuexiang Du et al.
CELL RESEARCH (2018)
Combination of Cytokine-Induced Killer Cells and Programmed Cell Death-1 Blockade Works Synergistically to Enhance Therapeutic Efficacy in Metastatic Renal Cell Carcinoma and Non-Small Cell Lung Cancer
Zibing Wang et al.
FRONTIERS IN IMMUNOLOGY (2018)
CIK as therapeutic agents against tumors
M. Introna
JOURNAL OF AUTOIMMUNITY (2017)
Renal cell carcinoma
James J. Hsieh et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Cytokine induced killer cell-based immunotherapies in patients with different stages of renal cell carcinoma
Xuan Zhao et al.
CANCER LETTERS (2015)
Association of Myeloid-derived Suppressor Cells and Efficacy of Cytokine-induced Killer Cell Immunotherapy in Metastatic Renal Cell Carcinoma Patients
Zibing Wang et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
Hiroshi Yano et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study
Jinying Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK
Qi-Jing Wang et al.
Chinese Journal of Cancer (2012)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Adenoviral vaccination combined with CD40 stimulation and CTLA-4 blockage can lead to complete tumor regression in a murine melanoma model
Maria R. Sorensen et al.
VACCINE (2010)
CD28 and CTLA-4 coreceptor expression and signal transduction
Christopher E. Rudd et al.
IMMUNOLOGICAL REVIEWS (2009)
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies
Karl S. Peggs et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
An agonist antibody specific for CD40 induces dendritic cell maturation and promotes autologous anti-tumour T-cell responses in an in vitro mixed autologous tumour cell/lymph node cell model
T. B. Hunter et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Cutting edge:: CTLA-4 (CD152) differentially regulates mitogen-activated protein kinases (extracellular signal-regulated kinase and c-Jun N-terminal kinase) in CD4+ T cells from receptor/ligand-deficient mice
H Schneider et al.
JOURNAL OF IMMUNOLOGY (2002)
CD40 ligand and CTLA-4 are reciprocally regulated in the Th1 cell proliferative response sustained by CD8+ dendritic cells
F Fallarino et al.
JOURNAL OF IMMUNOLOGY (2002)
Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb
D Ito et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
